Pricing Log in Create free account

Incyte Corporation (INCY) vs BeOne Medicines Ltd. - Sponsored ADR (ONC)

Incyte Corporation and BeOne Medicines Ltd. - Sponsored ADR are both Biotechnology companies. BeOne Medicines Ltd. - Sponsored ADR is the larger, with a market value of $40.4B against $24.1B — 1.7× the size. Incyte Corporation trades at the lower P/E: 56.3× against 65.9×. BeOne Medicines Ltd. - Sponsored ADR grew revenue faster over the last twelve months: 32.9% against 24.9%. BeOne Medicines Ltd. - Sponsored ADR has the higher net margin (13.9% vs 6.71%) and the higher return on invested capital (85.2% vs 21.6%). Across the 21 metrics below, BeOne Medicines Ltd. - Sponsored ADR leads on 11 and Incyte Corporation on 10.

Valuation

Metric INCY ONC Biotechnology median
P/E 56.33 65.91 10.26
P/S 4.00 6.57 9.18
P/B 4.26 7.45 2.05
Price to free cash flow 35.34 30.36 24.81
EV/EBITDA 27.88 28.56 0.65
EV/Sales 3.36 5.87 8.98
Earnings yield 1.78% 1.52% (34.89%)
Free cash flow yield 2.83% 3.29% (24.52%)

Profitability

Metric INCY ONC Biotechnology median
Gross margin 92.69% 89.39% 65.16%
Operating margin 10.42% 17.84% 0.00%
Net margin 6.71% 13.86% 0.00%
Free cash flow margin 11.31% 21.94% 0.00%
Return on equity 7.84% 18.40% (50.12%)
Return on assets 5.92% 10.46% (45.60%)
Return on invested capital 21.56% 85.21% 0.00%

Growth

Metric INCY ONC Biotechnology median
Revenue growth (TTM) 24.88% 32.86% 6.26%
EPS growth (last fiscal year) 4,173.33% 141.34% 29.88%
Revenue growth, 5-year CAGR 14.03% 76.85% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INCY ONC Biotechnology median
Debt to equity 0.00 0.14 0.00
Current ratio 3.84 3.55 4.89
Net debt to EBITDA (2.21) (6.09) 1.01

Dividend

Metric INCY ONC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INCY ONC Biotechnology median
Market cap 24.05b 40.38b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack